NLRP3 and cardiac hypertrophy: Several studies have suggested that modulating inflammasome activity can reduce myocardial hypertrophy and fibrosis [70], and it has been observed that people with a lower ejection fraction have a greater presence of cardiac neutrophils and a higher activity range of NLRP3 [71].